Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAP | Q12884 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30169842 | 1.00 | FAP (1.00) | FAP | |
| SCHEMBL26348944 | 1.00 | FAP (1.00) | FAP | |
| SCHEMBL26349148 | 0.97 | FAP (1.00) | FAP | |
| SCHEMBL30169765 | 0.92 | FAP (1.00) | FAP | |
| SCHEMBL25752735 | 0.92 | FAP (1.00) | FAP | |
| SCHEMBL26348966 | 0.92 | FAP (1.00) | FAP | |
| SCHEMBL30169843 | 0.90 | FAP (0.85) | FAP | |
| SCHEMBL30414389 | 0.89 | FAP (0.85) | FAP | |
| SCHEMBL25239559 | 0.89 | FAP (1.00) | FAP | |
| SCHEMBL25283860 | 0.89 | FAP (1.00) | FAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230192647-A1 | COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-06-22 | — | — | US | disclosed |
| US-20230192647-A1 | COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230192647-A1 | COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN | FAP, FIBP, APC | FAP 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.